Logotype for California Water Service Group

California Water Service Group (CWT) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for California Water Service Group

Q4 2025 earnings summary

26 Feb, 2026

Executive summary

  • Announced acquisitions of Nexus Water's Nevada and Oregon operations and full ownership of BVRT Holdings in Texas, expanding presence to eight states and diversifying regulatory exposure.

  • 2025 marked the 100th year of operations, with record $517 million infrastructure investment and continued focus on rate case progress and regulatory engagement.

  • Q4 and full-year 2025 results were negatively impacted by severe wet weather, reducing customer consumption and earnings.

  • Increased annual dividend by 10.71% in 2025 and announced a further 8% increase for 2026, marking the 59th consecutive annual increase.

  • Completed rate cases in Hawaii and Washington, supporting infrastructure upgrades and revenue growth.

Financial highlights

  • Q4 2025 revenue was $220 million, down from $222.2 million in Q4 2024; net income was $11.5 million ($0.19 per share) versus $19.7 million ($0.33 per share) year-over-year.

  • Full-year 2025 operating revenue was $1 billion, up 5.4% from non-GAAP 2024 revenue of $949.3 million; GAAP revenue declined 3.5% year-over-year.

  • Net income for 2025 was $128.2 million, up 1% from non-GAAP 2024 net income of $126.8 million; GAAP net income decreased 32.8% year-over-year.

  • Diluted EPS for 2025 was $2.15, essentially flat compared to non-GAAP 2024 EPS of $2.16; GAAP EPS declined from $3.25 in 2024.

  • Dividend per share was $1.24 in 2025, up from $1.12 in 2024, including a special dividend.

Outlook and guidance

  • Expecting timely completion and integration of Nexus and BVRT acquisitions.

  • Anticipate a decision soon on the 2024 California General Rate Case, with planning underway for the 2027 rate case.

  • Continued focus on infrastructure investment, regulatory engagement, and disciplined capital allocation.

  • PFAS treatment program to continue, with $50–$70 million in spending expected in 2026 and majority of treatment in place by end of 2027; $235.3 million in additional PFAS-related capital expenditures expected over multiple years.

  • Rate base projected to exceed $3.3 billion by 2027, with an 11.7% CAGR from 2018–2027.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more